-
Recent Posts
- Evidence on the Potential of the Arts for Improving Mental and Physical Health and Wellbeing (WHO)
- Demand for Mental Health Inpatient Beds in England (BBC News / NHS Strategy Unit)
- Dementia Services in England: Mega Statistical Package (PHE / NMHDNIN)
- Mandatory Learning Disability and Autism Awareness Training for NHS Staff (DHSC / BBC News)
- Detention of Children and Young People With Learning Disabilities and/or Autism (Joint Committee on Human Rights / BBC News)
Archives
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: Differemtial Antipsychotic-Related Mortality Risks
Reducing Antipsychotic Prescriptions for Dementia in Primary Care (HSJ / NHS London)
Summary The Dementia and Prescribing Antipsychotic Project, run by London-based CCGs, helped to reduce prescribing levels by between 48% and 77%. The project aimed to raise awareness of the risks of antipsychotic prescribing for behavioural and psychological symptoms in dementia. … Continue reading →
Posted in Antipsychotics, Commissioning, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, NHS, Non-Pharmacological Treatments, Patient Care Pathway, Patient Information, Person-Centred Care, Pharmacological Treatments, Practical Advice, Quick Insights, Standards, UK, Universal Interest
|
Tagged Antipsychotic Drugs, Antipsychotic Prescribing in Care Homes, Antipsychotic Prescribing in Nursing Homes, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics Limitation in Dementia, Antipsychotics Side Effects, Antipsychotics-Related Mortality Risks, Antipsychotics: Neuroleptic Sensitivity, Atypical Antipsychotics, Behavioural and Psychological Symptoms of Dementia (BPSD), Bexley, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, Bromley, Care Homes, CCGs, Clinical Commissioning Groups (CCGs), Community Care, Community Care Services, Community Pharmacists, Croydon, Dementia and Prescribing Antipsychotic Project, Differemtial Antipsychotic-Related Mortality Risks, Differential Risk of Death (Antipsychotic Drugs), Distressed Behaviour, East and South East Specialist Pharmacy Services, General Practice, GP Clusters, GPs, Guideline on Supporting People with Dementia and Their Carers in Health and Social Care, Guys and St Thomas Foundation Trust, Health Service Journal (HSJ), Home and Community Care Services, HSJ, Inappropriate Use of Antipsychotics in Dementia, Integrated Care Services, Integrated Commissioning, Integration of Pharmacy Into Community Care, Local Commissioning, London Antipsychotics Audit and Reduction Exercise in Primary Care, London GP Practice Audit of Antipsychotic Prescribing to People With Dementia, London Primary Care, Managing Medicines in Care Homes, Managing Psychological and Behavioural Distress in People with Dementia, Medicines Management, Medicines Management Audits, Mental Health Pharmacists, NHS London, NHSL Antipsychotic GP Audit, NICE Clinical Guideline 42. Dementia: Supporting People With Dementia And Their Carers In Health And Social Care, NICE–SCIE Guideline on Supporting People with Dementia and Their Carers in Health and Social Care, Pharmacists, Prescribing Anti-Psychotic Drugs to People with Dementia, Primary Care, Psychological Symptoms of Dementia (BPSD), Quality and Outcomes Framework (QOF), Reducing Agitation and Distress, Reducing Antipsychotic Medication in Care Homes, Reducing Antipsychotic Prescriptions in Dementia, Reducing Inappropriate Use of Antipsychotics in Dementia, Richmond, Supporting People with Dementia and Their Carers in Health and Social Care, Wandsworth
|
Leave a comment
Reducing Antipsychotic Drugs in Care Homes (Nursing Times)
Summary A recent Nursing Times articles covers the use of antipsychotic drugs for people with dementia living in care homes. It discusses a review by pharmacists which resulted in the use of these drugs being reduced or discontinued. It covers … Continue reading →
Posted in Antipsychotics, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, Patient Care Pathway, Person-Centred Care, Pharmacological Treatments, Practical Advice, Quick Insights, RCN, Standards, UK, Universal Interest
|
Tagged Alternatives to Antipsychotic Medication, AntiCholinergic Burden Scale, Anticholinergic Discontinuation, Anticholinergic Drugs, Anticholinergics, Antipsychotic Drugs, Antipsychotic Prescribing in Care Homes, Antipsychotic Prescribing in Nursing Homes, Antipsychotics Side Effects, Antipsychotics-Related Mortality Risks, Atypical Antipsychotics, Behavioural and Psychological Symptoms of Dementia (BPSD), Boots Care Services, Boots UK, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, Care Homes, Differemtial Antipsychotic-Related Mortality Risks, Differential Risk of Death (Antipsychotic Drugs), Inappropriate Use of Antipsychotics in Dementia, Managing Medicines in Care Homes, Nursing Times, Quetiapine, Reducing Antipsychotic Drugs in Care Homes, Reducing Antipsychotic Medication in Care Homes, Reducing Inappropriate Use of Antipsychotics in Dementia, School of Pharmacy: University of East Anglia, University of East Anglia
|
Leave a comment
Whole-Person Care: Towards Parity Between Mental and Physical Health (Royal College of Psychiatrists)
Summary This Royal College of Psychiatrists report discusses steps to achieve greater “parity of esteem” for mental health compared with physical health services. “…mental health does not receive the same attention as physical health. People with mental health problems frequently … Continue reading →
Posted in Acute Hospitals, Antipsychotics, Commissioning, Community Care, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, NHS, Patient Care Pathway, Person-Centred Care, Pharmacological Treatments, Quick Insights, Royal College of Psychiatrists, Standards, UK, Universal Interest
|
Tagged Acute Hospital Care, Acute Hospitals, Adult Mental Health Services (AMHS), Antipsychotics and Risk of Venous Thromboembolism, Community Mental Health, Community Mental Health Services, Dementia Care in Acute General Hospitals, Dementia Care in the Acute Hospital, Differemtial Antipsychotic-Related Mortality Risks, Discrimination, Early-Onset Dementia, Elderly Mental Health, JCP-MH: Joint Commissioning Panel for Mental Health, Joint Commissioning Panel for Mental Health (JCP-MH), Lester UK Adaptation, Lester UK Adaptation: Positive Cardiometabolic Health Resource, Liaison Mental Health Services, Mental Health Awareness, Mental Health Recovery, Mental Health Services, Mental Health Strategy, Mental Healthcare, Ministerial Advisory Group on Mental Health Strategy (MAGMHS), Multi-Disciplinary Working, Multidisciplinary Team Care, Multimorbidity, Multiple Needs, Multiple-Morbidities, NHS Outcomes Framework, NHS Outcomes Framework Domains, NHSOF: NHS Outcomes Framework, No Health Without Mental Health, Older Adult Mental Health Services (OAMHS), Parity Between Mental and Physical Health, Parity Commitments, Stigma, Whole-Person Care, Young Onset Dementia (YOD)
|
Leave a comment
Comparative Mortality Risks from Antipsychotics in Community-Dwelling Older Adults (British Journal of Psychiatry)
Summary A US observational study of 136,393 people, aged 65 years and older, and living in the community, who had recently started taking antipsychotics, was performed to estimate the comparative mortality risks of commonly prescribed antipsychotics. These individuals had recently … Continue reading →
Posted in Antipsychotics, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Pharmacological Treatments, Practical Advice, Quick Insights
|
Tagged Antipsychotic Drugs, Antipsychotic Prescribing in Nursing Homes in the United States, Antipsychotics, Antipsychotics in Elderly People with Dementia, Antipsychotics-Related Mortality Risks, Aripiprazole, Atypical Antipsychotics, Avoidable Mortality, Boston, Brigham and Women's Hospital and Harvard Medical School, British Journal of Psychiatry, College of Physicians and Surgeons: Columbia University, Columbia University, Community-Dwelling Older Adults, Comparative Mortality Risks from Antipsychotics, Department of Medicine: Brigham and Women's Hospital and Harvard Medical School, Department of Pharmacy Practice and Administration: Rutgers University, Department of Psychiatry: Columbia University, Department of Psychiatry: Duke University Medical Center, Department of Psychiatry: Vanderbilt University School of Medicine, Differemtial Antipsychotic-Related Mortality Risks, Differential Risk of Death (Antipsychotic Drugs), Division of Pharmacoepidemiology and Pharmacoeconomics: Brigham and Women's Hospital and Harvard Medical School, Duke University Medical Center, Ernest Mario School of Pharmacy: Rutgers University, Haloperidol, Health Care Policy and Aging Research: Rutgers University, Institute for Health, Institute for Health: Rutgers University, Massachusetts, Mortality Rates, Mortality Statistics, New Brunswick, New Jersey, New York, New York State Psychiatric Institute, Olanzapine, Prescribing of Antipsychotic Drugs For People With Dementia, Preventable Mortality, Quetiapine, Reducing Antipsychotic Medication in Care Homes, Risperidone, Rutgers University, USA, Vanderbilt University School of Medicine, Ziprasidone
|
Leave a comment
Neuroleptic, Sedative and Analgesic Prescription in Dementia Patients Admitted into an Acute Hospital (Royal Wolverhampton NHS Trust / Nursing Standard / YouTube)
Summary The aim of the research reported in this conference poster presentation was to assess the use of neuroleptics, sedatives and analgesics in patients with dementia at the Royal Wolverhampton NHS Trust. Drug charts of 51 patients were examined to … Continue reading →
Posted in Acute Hospitals, For Doctors (mostly), For Nurses and Therapists (mostly), International, Local Interest, Management of Condition, Models of Dementia Care, New Cross Dementia Project, New Cross Hospital, NHS, Pain, Pharmacological Treatments, Practical Advice, Quick Insights, Royal Wolverhampton NHS Trust, Royal Wolverhampton NHS Trust Authorial Affiliation, UK, Wolverhampton
|
Tagged American Geriatric Society Conference (Arizona) October 2012, American Geriatrics Society, Antipsychotic Drugs, Antipsychotics, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics in Elderly People with Dementia, Antipsychotics-Related Mortality Risks, Arizona Geriatrics Society (AzGS), Behavioral and Psychological Symptoms of Dementia (BPSD), BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, Call to Action on Antipsychotic Drugs (Dementia Action Alliance), Dementia Action Week, Dementia Action Week (2018), Differemtial Antipsychotic-Related Mortality Risks, Neuroleptics, OUCH! Campain: Observe Understand Communicate and Help, OUCH! Mnemonic, Pain Control and Dementia in the Acute Hospital, Pain Management, Pain Relief, Painkillers, Prescribing of Antipsychotic Drugs For People With Dementia, Treatment of Pain to Reduce Behavioural Disturbances, Untreated Pain, YouTube
|
Leave a comment
Low Dose Antipsychotics in People with Dementia (NICE ADA)
[A version of this item appears in: Dementia and Elderly Care: the Latest Evidence Newsletter (RWHT), Volume 3 Issue 3, October 2012]. Summary NICE has produced a series of academic detailing aids (ADAs) from “NPC Key Therapeutic Topics: medicines management … Continue reading →
Posted in Acute Hospitals, Antipsychotics, Community Care, For Doctors (mostly), For Researchers (mostly), Management of Condition, National, NICE Guidelines, Pharmacological Treatments, Quick Insights
|
Tagged Academic Detailing Aids (ADAs), Antipsychotic Drugs, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics in Elderly People with Dementia, Atypical Antipsychotics, Behavioral and Psychological Symptoms of Dementia (BPSD), BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, Call to Action on Antipsychotic Drugs (Dementia Action Alliance), Differemtial Antipsychotic-Related Mortality Risks, Differential Risk of Death (Antipsychotic Drugs), Low Dose Antipsychotics, NICE ADA, NPC Key Therapeutic Topics, Prescribing of Antipsychotic Drugs For People With Dementia
|
Leave a comment
Steps to Reduce Antipsychotic Use for Nursing Home Residents with Dementia in the USA (CMS / JAMA)
Summary Inappropriate prescribing of antipsychotics for nursing home patients is a recognised problem in the United States. The US Food and Drug Administration, back in 2005, issued a public health advisory warning alerting that treatment of behavioural disorders in elderly … Continue reading →
Posted in Antipsychotics, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), International, Management of Condition, Non-Pharmacological Treatments, Pharmacological Treatments, Proposed for Next Newsletter, Quick Insights, Universal Interest
|
Tagged Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics in Elderly People with Dementia, Atypical Antipsychotics, Behavioral and Psychological Symptoms of Dementia (BPSD), Behavioural Alternatives to Antipsychotic Drugs, BPSD: Behavioral and Psychological Symptoms of Dementia, Centers for Medicare & Medicaid Services (CMS), Centers for Medicare and Medicaid Services (U.S.), Differemtial Antipsychotic-Related Mortality Risks, Inappropriate Prescribing, Nursing Homes, Nursing Homes in the United States, Partnership to Improve Dementia Care (CMS), Patient-Centered Care, Person-Centered Care, Person-Centred Dementia Care, Psychological Symptoms of Dementia (BPSD), United States
|
Leave a comment
